MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Accelerate Diagnostics Company Profile (NASDAQ:AXDX)

Consensus Ratings for Accelerate Diagnostics (NASDAQ:AXDX) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $22.67 (57.08% upside)

Analysts' Ratings History for Accelerate Diagnostics (NASDAQ:AXDX)
Show:
DateFirmActionRatingPrice TargetActions
6/15/2016BTIG ResearchReiterated RatingBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Piper JaffrayReiterated RatingOverweight$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2016JPMorgan Chase & Co.Initiated CoverageOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Accelerate Diagnostics (NASDAQ:AXDX)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Accelerate Diagnostics (NASDAQ:AXDX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Accelerate Diagnostics (NASDAQ:AXDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Accelerate Diagnostics (NASDAQ:AXDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/14/2016Jack W SchulerDirectorBuy14,033$13.67$191,831.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2016Jack W SchulerDirectorBuy15,967$13.70$218,747.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2016Jack W SchulerDirectorBuy88,316$14.69$1,297,362.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Jack W SchulerDirectorBuy101,272$14.14$1,431,986.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Jack W SchulerDirectorBuy4,270$11.04$47,140.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Jack W SchulerDirectorBuy10,000$11.45$114,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Jack W SchulerDirectorBuy11,511$11.91$137,096.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Jack W SchulerDirectorBuy20,000$12.45$249,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016Jack W SchulerDirectorBuy600,000$11.86$7,116,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Jack W SchulerDirectorBuy20,000$12.32$246,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Jack W SchulerDirectorBuy7,308$12.65$92,446.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2016Jack W SchulerDirectorBuy10,000$12.98$129,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Jack W SchulerDirectorBuy50,100$13.09$655,809.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2016Jack W SchulerDirectorBuy20,000$13.46$269,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2016Jack W SchulerDirectorBuy10,000$15.02$150,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Larry N FeinbergMajor ShareholderBuy117,647$17.00$1,999,999.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2015Jack W SchulerDirectorBuy11,899$16.81$200,022.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015Jack W SchulerDirectorBuy52,837$16.81$888,189.97View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/22/2015Jack W SchulerDirectorBuy2,160$15.82$34,171.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/29/2015Brink Frank Jm TenDirectorBuy9,800$15.24$149,352.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2015Jack W SchulerDirectorBuy10,000$17.81$178,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Jack W SchulerDirectorBuy10,000$18.56$185,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/17/2015Jack W SchulerDirectorBuy11,000$21.94$241,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Matthew StrobeckDirectorBuy2,000$22.04$44,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Jack W SchulerDirectorBuy22,584$17.18$387,993.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Jack W SchulerDirectorBuy18,000$18.93$340,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2014Jack W SchulerDirectorBuy2,588$16.44$42,546.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014Jack W SchulerDirectorBuy32,411$16.67$540,291.37View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2014Jack W SchulerDirectorBuy2,900$16.79$48,691.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Larry N FeinbergMajor ShareholderBuy11,835$15.92$188,413.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2014Larry N FeinbergMajor ShareholderBuy20,000$21.54$430,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Jack W SchulerDirectorBuy8,698$25.70$223,538.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014Jack W SchulerDirectorBuy10,000$26.09$260,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014Larry N FeinbergMajor ShareholderBuy20,000$25.72$514,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Larry N FeinbergMajor ShareholderBuy297,618$16.80$4,999,982.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2014Larry N FeinbergMajor ShareholderBuy8,554$24.78$211,968.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2014Larry N FeinbergMajor ShareholderBuy16,307$13.09$213,458.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2013Larry N FeinbergMajor ShareholderBuy84,081$12.29$1,033,355.49View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013Larry N FeinbergMajor ShareholderBuy10,000$12.95$129,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013Larry N FeinbergMajor ShareholderBuy16,001$9.76$156,169.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013Larry N FeinbergMajor ShareholderBuy158,445$9.80$1,552,761.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013Jack W SchulerDirectorBuy78,494$7.88$618,532.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Jack W SchulerDirectorBuy413,090$8.04$3,321,243.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Larry N FeinbergMajor ShareholderBuy36,814$7.24$266,533.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2013Larry N FeinbergMajor ShareholderBuy35,168$7.30$256,726.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2013Larry N FeinbergMajor ShareholderBuy114,250$8.00$914,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2013Larry N FeinbergMajor ShareholderBuy7,175$8.41$60,341.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Larry N FeinbergMajor ShareholderBuy45,508$8.33$379,081.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Accelerate Diagnostics (NASDAQ:AXDX)
DateHeadline
06/27/16 02:20 PMGenMark, T2 And Accelerate Diagnostics Impress Analysts At Microbiology Forum - Benzinga
06/27/16 07:24 AMAccelerate Diagnostics, Inc. (AXDX) Broker Price Targets For The Coming Week - Fiscal Standard
06/25/16 02:41 PMAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Shorted Shares Increased 5.45% After Market Selling - Engelwood Daily
06/24/16 07:51 PMNew Broker Ratings For Accelerate Diagnostics, Inc. (AXDX) - FTSE News
06/24/16 04:24 PMETF’s with exposure to Accelerate Diagnostics, Inc. : June 24, 2016 -
06/24/16 07:23 AMAccelerate Diagnostics, Inc. (AXDX) Updated Price Targets - FTSE News
06/18/16 07:25 AMAccelerate Diagnostics Inc. (AXDX) is Trading Lower on Unusual Volume for June 16 - Equities.com
06/16/16 02:43 PMAccelerate Diagnostics Inc. (NASDAQ:AXDX) announced the completion of clinical data collection - Inside Trade
06/15/16 07:32 AMAccelerate Diagnostics Inc. (AXDX) Drops 7.46% on June 13 - Equities.com
06/14/16 07:29 PMAccelerate Diagnostics Completes Clinical Data Collection, Will Present Data at the William Blair 36th Annual Growth Stock Conference - [at noodls] - 7ff0a305-b1f2-408c-abd9-94d79f8a44f1.pdf June 14, 2016 TUCSON, Ariz., June 14, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. ("Accelerate") announced today the completion of clinical ...
06/09/16 02:42 PMAccelerate Diagnostics, Inc. (NasdaqCM:AXDX) Fundamental Star Rating Report - CML News
06/08/16 11:12 AMACCELERATE DIAGNOSTICS INC. (NASDAQ:AXDX) Financial Condition Compared to S&P 500 - CML News
06/07/16 06:28 PMAccelerate Diagnostics to Present at the 36th Annual Growth Stock Conference - [at noodls] - 5b580007-aa63-4c9a-aa1c-003585fcbd01.pdf June 7, 2016 TUCSON, Ariz., June 07, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, the company's president and chief ...
06/03/16 02:46 PMAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Stock Update & Estimates - Stock Tick Tock
06/03/16 02:46 PMNews Sentiment For Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Investor Newswire
06/03/16 02:10 PMETF’s with exposure to Accelerate Diagnostics, Inc. : June 3, 2016 -
06/01/16 11:08 AMAccelerate Diagnostics, Inc. (AXDX) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Accelerate Diagnostics, Inc. (AXDX) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Accelerate Diagnostics, Inc. (AXDX). The latest reports which are currently in issue on Wednesday 1st of June state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
05/28/16 12:35 AMAccelerate Diagnostics Inc (AXDX) Drops 6.39% on May 26 - Equities.com - share market updates (press release)Accelerate Diagnostics Inc (AXDX) Drops 6.39% on May 26Equities.comAccelerate Diagnostics Inc (AXDX) was one of the Russell 2000's biggest losers for Thursday May 26 as the stock slid 6.39% to $12.30, a loss of $-0.84 per share. Starting at an opening price of $13.16 a share, the stock traded between $12.15 and $13.16 ...Accelerate Diagnostics, Inc. (AXDX) Updated Analyst CoverageRisers & FallersLatest Analyst Ratings For Accelerate Diagnostics, Inc. (AXDX)Share Trading NewsAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Quarterly EPS From Continuing Operations Stands At $-0.2944Equities Focusshare market updates (press release) -The Post -Wall Street Hints and Newsall 7 news articles »
05/26/16 07:07 AMAccelerate Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : AXDX-US : May 26, 2016 -
05/22/16 11:42 AMAccelerate Diagnostics, Inc. (NASDAQ:AXDX) One-Year Price Projection At $21 - Investor Newswire - Accelerate Diagnostics, Inc. (NASDAQ:AXDX) One-Year Price Projection At $21Investor NewswireSell-side analysts are certain on the prospect of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) stock. As of 2016-05-21, the stock ABR stands at 1. This type of rating states that whenever a stock has a score of 5, investors should avoid investing in such ...and more »
05/21/16 06:29 PMAlpha One Assigns Impact Score Of 50 To Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - RealistInvestor.com - Alpha One Assigns Impact Score Of 50 To Accelerate Diagnostics, Inc. (NASDAQ:AXDX)RealistInvestor.comAlpha One analyzed the various web articles published on Accelerate Diagnostics, Inc. (NASDAQ:AXDX), and thereafter it gave company a daily sentiment score of 0. The entity designs algorithm based assessment to known stock sentiment on stock after ...and more »
05/19/16 06:01 PMETF’s with exposure to Accelerate Diagnostics, Inc. : May 19, 2016 -
05/18/16 06:58 PMNotable Tuesday Option Activity: AXDX, COTY, LOW - Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Accelerate Diagnostics Inc (Symbol: AXDX), where a total of 5,025 contracts have traded so far, representing approximately 502,500 underlying shares.
05/17/16 01:02 PMAccelerate Diagnostics, Inc. :AXDX-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/16/16 12:21 PMAccelerate Diagnostics, Inc. (NASDAQ:AXDX) One-Year Mean Price Target At $21 - Investor Newswire - Accelerate Diagnostics, Inc. (NASDAQ:AXDX) One-Year Mean Price Target At $21Investor NewswireSell-side analysts are confident on the future outlook of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) stock. As of 2016-05-14, the stock has an ABR of 1 rating, where number 5 denotes a Strong Sell and 1 Strong Buy. The ABR is reached on the basis of ...and more »
05/16/16 07:40 AMAccelerate Diagnostics (AXDX) Jumps: Stock Rises 6.1% -
05/13/16 07:16 PMAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Short Interest Decreased By 2.62% - Wall Street Hints and News - Accelerate Diagnostics Incorporated (NASDAQ:AXDX) Short Interest Decreased By 2.62%Wall Street Hints and NewsAbout 257,872 shares traded hands or 30.05% up from the average. Accelerate Diagnostics Inc (NASDAQ:AXDX) has declined 31.14% since October 7, 2015 and is downtrending. It has underperformed by 34.56% the S&P500. Accelerate Diagnostics, Inc. is ...and more »
05/13/16 04:22 PMACCELERATE DIAGNOSTICS, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
05/12/16 06:07 AMQ1 2016 Accelerate Diagnostics Inc Earnings Release - After Market Close -
05/11/16 07:35 PMAccelerate Diagnostics Inc (AXDX) Scheduled to Post Earnings on Thursday - Washington News Wire - Washington News WireAccelerate Diagnostics Inc (AXDX) Scheduled to Post Earnings on ThursdayWashington News WireAccelerate Diagnostics logo Accelerate Diagnostics Inc (NASDAQ:AXDX) is scheduled to be releasing its Q116 earnings data on Thursday, May 12th. Analysts expect Accelerate Diagnostics to post earnings of ($0.28) per share for the quarter. Accelerate ...Accelerate Diagnostics, Inc. (AXDX) Updated Analyst CoverageRisers & FallersAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Basic Consolidated EPS At $-1.0111Equities FocusAccelerate Diagnostics, Inc. (NASDAQ:AXDX) To Release Earnings On ThursdayShare Trading Newsall 5 news articles »
05/10/16 04:55 PMACCELERATE DIAGNOSTICS, INC Files SEC form 10-Q, Quarterly Report -
05/09/16 03:46 PMACCELERATE DIAGNOSTICS, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/08/16 08:45 PMAccelerate Diagnostics, Inc. (AXDX) Broker Price Targets For The Coming Week - Share Trading News - Accelerate Diagnostics, Inc. (AXDX) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Accelerate Diagnostics, Inc. (AXDX). The latest reports which are currently in issue on Sunday 8th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...and more »
05/07/16 06:29 PMAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Boasts An Average Rating Of 4.2 - RealistInvestor.com - Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Boasts An Average Rating Of 4.2RealistInvestor.comAlpha One applies algorithm-based analytics for assessing a stock sentiment as per the published released on web channels. In this evaluation process, the group accesses the most relevant news platforms on a daily basis. Accelerate Diagnostics, Inc.
05/05/16 08:08 PMNotable Thursday Option Activity: AXDX, LOCO, DATA - Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Accelerate Diagnostics Inc (Symbol: AXDX), where a total volume of 5,584 contracts has been traded thus far today, a contract volume which ...
05/04/16 07:16 PMAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Short Interest Increased By 2.8% - B.O.D.Y Confidential - Accelerate Diagnostics Incorporated (NASDAQ:AXDX) Short Interest Increased By 2.8%B.O.D.Y ConfidentialAccelerate Diagnostics Inc (NASDAQ:AXDX) has declined 23.10% since September 28, 2015 and is downtrending. It has underperformed by 32.75% the S&P500. Accelerate Diagnostics, Inc. is an in vitro diagnostics firm engaged in providing solutions that ...
05/01/16 09:10 PMAccelerate Diagnostics, Inc. (NASDAQ:AXDX) ABR Of 1 - Investor Newswire - Accelerate Diagnostics, Inc. (NASDAQ:AXDX) ABR Of 1Investor NewswireAnalysts have a buy call on Accelerate Diagnostics, Inc. (NASDAQ:AXDX) stock. As of 2016-04-30, it had an ABR of 1. The rating is fixed on a scale of 1-5. Here three stands for hold call. This analyst brokerage rating computation is based on 2 calls.and more »
04/29/16 07:32 PMCommit To Buy Accelerate Diagnostics At $10, Earn 19.8% Annualized Using Options - Investors eyeing a purchase of Accelerate Diagnostics Inc (AXDX) shares, but tentative about paying the going market price of $12.57/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put ...
04/25/16 09:45 PMAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Shorted Shares Decreased By 6.77% - B.O.D.Y Confidential - Accelerate Diagnostics Incorporated (NASDAQ:AXDX) Shorted Shares Decreased By 6.77%B.O.D.Y ConfidentialThe short interest to Accelerate Diagnostics Incorporated's float is 26.48%. The stock is down 0.44% or $0.06 after the news, hitting $13.43 per share. About 27,953 shares traded hands. Accelerate Diagnostics Inc (NASDAQ:AXDX) has declined 25.80% since ...and more »
04/25/16 09:45 PMAccelerate Diagnostics Schedules First-Quarter 2016 Results Announcement and Webcast - GlobeNewswire (press release) - Accelerate Diagnostics Schedules First-Quarter 2016 Results Announcement and WebcastGlobeNewswire (press release)Accelerate Diagnostics, Inc. (“Accelerate Diagnostics,”) (Nasdaq:AXDX), is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. The company's fully ...
04/25/16 04:56 PMAccelerate Diagnostics Schedules First-Quarter 2016 Results Announcement and Webcast - [at noodls] - e16fbc6e-fcea-4f03-9669-cf8f94bdc2d9.pdf April 25, 2016 TUCSON, Ariz., April 25, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report first- quarter 2016 financial results ...
04/20/16 08:22 PMAccelerate Diagnostics Inc (AXDX) Jumps 5.47% on April 20 - Equities.com - Accelerate Diagnostics Inc (AXDX) Jumps 5.47% on April 20Equities.comAccelerate Diagnostics Inc (AXDX) was among the biggest gainers on the Russell 2000 for Wednesday April 20 as the stock popped 5.47% to $13.68, representing a gain of $0.71 per share. Some 215,252 shares traded hands on 1,385 trades, compared with ...Will Accelerate Diagnostics Inc Go Down Anytime Soon?Franklin Independentall 2 news articles »
04/19/16 02:48 PMETF’s with exposure to Accelerate Diagnostics, Inc. : April 19, 2016 -
04/15/16 02:42 AMBroker Roundup For Accelerate Diagnostics, Inc. (AXDX) - Share Trading News - Broker Roundup For Accelerate Diagnostics, Inc. (AXDX)Share Trading News12/31/2015 – Accelerate Diagnostics, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 25 price target on the stock. The share price of Accelerate Diagnostics, Inc. (AXDX) was up +0.00% during the last ...
04/14/16 09:32 PMLatest Analyst Ratings For Accelerate Diagnostics, Inc. (AXDX) - Share Trading News - Mas Market NewsLatest Analyst Ratings For Accelerate Diagnostics, Inc. (AXDX)Share Trading NewsAccelerate Diagnostics, Inc. has a 50 day moving average of 13.08 and a 200 day moving average of 16.10. The stock's market capitalization is 603.07M, it has a 52-week low of 10.29 and a 52-week high of 31.29. The share price of the company (AXDX) was ...Accelerate Diagnostics Inc (AXDX) Rating Reiterated by BTIG ResearchMas Market Newsall 2 news articles »
04/14/16 09:32 PMPiper Jaffray Reaffirms “Buy” Rating for Accelerate Diagnostics Inc (AXDX) - Washington News Wire - Piper Jaffray Reaffirms “Buy” Rating for Accelerate Diagnostics Inc (AXDX)Washington News WireAccelerate Diagnostics Inc logo Piper Jaffray reaffirmed their buy rating on shares of Accelerate Diagnostics Inc (NASDAQ:AXDX) in a report issued on Monday, MarketBeat reports. Accelerate Diagnostics (NASDAQ:AXDX) traded up 0.15% during trading on ...Brokerages Expect Accelerate Diagnostics Inc (NASDAQ:AXDX) to Post ($0.25) EPSThe Vista VoiceAccelerate Diagnostics, Inc. (AXDX) Latest Broker CoverageRisers & Fallersall 3 news articles »
03/24/16 05:14 AMCoverage initiated on Accelerate Diagnostics by JP Morgan -
03/18/16 12:19 PMETF’s with exposure to Accelerate Diagnostics, Inc. : March 18, 2016 -
03/15/16 12:04 PMACCELERATE DIAGNOSTICS, INC Financials -
03/14/16 09:09 AMAccelerate Diagnostics, Inc. :AXDX-US: Earnings Analysis: Q4, 2015 By the Numbers -
About Accelerate Diagnostics

Accelerate Diagnostics logoAccelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that improve patient outcomes and lower healthcare costs through the diagnosis of serious infections. The Company's technology platform is built to address these challenges by delivering testing of infectious pathogens in various patient sample types. The Company is focused on the development of a rapid diagnostic platform, the Accelerate ID/AST System (ID/AST System or Accelerate ID/AST System), intended for the diagnosis of infectious pathogens. The ID/AST System utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. The ID/AST System features walk-away automation and consists of a fixed instrument and single-use test kit.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AXDX
  • CUSIP:
Key Metrics:
  • Previous Close: $14.96
  • 50 Day Moving Average: $13.36
  • 200 Day Moving Average: $14.70
  • P/E Ratio: N/A
  • P/E Growth: -0.40
  • Market Cap: $740.61M
  • Current Quarter EPS Consensus Estimate: $-1.27 EPS
Additional Links:
Accelerate Diagnostics (NASDAQ:AXDX) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha